Methylphenidate Has Superior Efficacy Over Parent-Child Interaction Therapy for Preschool Children with Disruptive

Lianne van der Veen-Mulders1, Barbara J van den Hoofdakker1,2, Maaike H Nauta2

  • 11 Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen , Groningen, The Netherlands .

Insights

Methylphenidate showed greater effectiveness than parent-child interaction therapy (PCIT) for reducing behavior problems and ADHD symptoms in preschoolers. Both treatments may help children with disruptive behaviors, but more research is needed.

Area of Science:

  • Child Psychology
  • Behavioral Therapy
  • Pediatric Pharmacology

Background:

  • Preschoolers with attention-deficit/hyperactivity disorder (ADHD) symptoms often exhibit disruptive behaviors.
  • Previous behavioral parent training may not fully resolve significant behavior problems in young children.
  • Parent-child interaction therapy (PCIT) and methylphenidate are potential treatment options.

Purpose of the Study:

  • To compare the effectiveness of PCIT and methylphenidate for preschool children with ADHD symptoms and disruptive behaviors.
  • To evaluate treatment outcomes after previous behavioral parent training.
  • To assess changes in behavior problem intensity, number, and ADHD symptom severity.

Main Methods:

  • A randomized controlled trial involving 35 preschool children (ages 3.4-6.0 years).
  • Participants were assigned to either PCIT (n=18) or methylphenidate (n=17).
  • Maternal ratings of behavior problems and ADHD symptoms were compared pre- and post-treatment, with additional comparisons to a care-as-usual group.

Main Results:

  • Methylphenidate led to a significantly greater decrease in behavior problem intensity compared to PCIT.
  • ADHD symptoms significantly reduced over time only in the methylphenidate group.
  • No significant changes in behavior problems were observed in the care-as-usual group.

Conclusions:

  • Methylphenidate demonstrated higher effectiveness than PCIT in this study.
  • Both PCIT and methylphenidate may offer benefits for preschool children with disruptive behaviors.
  • Findings are preliminary due to small sample size and limited safety data for methylphenidate in preschoolers; further research is warranted.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
550
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
522
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K